A detailed history of Fmr LLC transactions in Biovie Inc. stock. As of the latest transaction made, Fmr LLC holds 2,943 shares of BIVI stock, worth $8,152. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,943
Previous 6,180 52.38%
Holding current value
$8,152
Previous $3,000 66.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$0.4 - $0.56 $1,294 - $1,812
-3,237 Reduced 52.38%
2,943 $1,000
Q1 2024

May 13, 2024

BUY
$0.53 - $1.89 $3,183 - $11,353
6,007 Added 3472.25%
6,180 $3,000
Q4 2023

Feb 13, 2024

SELL
$1.22 - $5.24 $242 - $1,042
-199 Reduced 53.49%
173 $0
Q3 2023

Nov 13, 2023

BUY
$2.75 - $5.17 $805 - $1,514
293 Added 370.89%
372 $1,000
Q2 2023

Aug 11, 2023

BUY
$4.09 - $8.29 $323 - $654
79 New
79 $0

Others Institutions Holding BIVI

About BIOVIE INC.


  • Ticker BIVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 30,165,300
  • Market Cap $83.6M
  • Description
  • BioVie Inc., a clinical stage biotechnology company, engages in the discovery, development, and commercialization of drugs therapies in the United States. Its products in pipeline include BIV201, which completed Phase IIa clinical trial for the treatment of ascites due to chronic liver cirrhosis; and NE3107, which is in Phase III clinical trial ...
More about BIVI
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.